Our Team
Scientists and builders who originate conviction.
MEET THE TEAM
RYAN BERRY, PhD
Analyst
SHAN SHAN WANG, PhD
Associate
JESSE CHEN, PhD
Entrepreneur in Residence
KATE MOREAU, PhD
Associate Director
EMILY GREEN
Senior Graphic Designer
MATTHEW THERKELSEN, PhD
Associate
RYAN BERRY, PhD
Analyst
Ryan Berry is an Analyst on the Investment Team at RA Capital Management. Ryan’s primary responsibility at RA Capital is to is to conduct due diligence on biotechnology companies. Prior to this role, Ryan was an Associate on the Cardio-Renal Team within the TechAtlas division of RA Capital, where he mapped competitive landscapes of drugs and medical devices for disease indications and capabilities, with a focus on coronary artery disease, stroke, and dyslipidemia. Ryan holds a BS in Biochemistry and Molecular Cell Biology from the University of Minnesota, Twin Cities, and a PhD in Molecular, Cellular and Developmental Biology from Yale University. His doctoral research focused on cellular mechanisms of adipogenesis.
SHAN SHAN WANG, PhD
Associate
Shan Shan is an Associate within the TechAtlas division of RA Capital Management. Shan Shan’s primary responsibility is to create competitive landscapes of drugs and medical devices for disease indications and capabilities. Shan Shan holds a PhD in Neuroscience from Harvard University and a BS in Brain and Cognitive Sciences from MIT.
JESSE CHEN, PhD
Entrepreneur in Residence
Jesse Chen is an EIR at RA Capital. In this role he works closely with RA’s Venture Team to evaluate various drug discovery platforms and initiate novel therapeutics programs. Jesse has more than a decade of discovery research and management experience, from early discovery through preclinical development. Prior to joining RA, Jesse was Senior Director of Discovery at Kymera Therapeutics. As the first and founding member of Kymera’s scientific team, Jesse was responsible for building the company’s industry-leading targeted protein degradation platform and pipeline, and he helped secure the company’s Series A and B financings as well as a partnership with Vertex. Jesse also held research leadership roles at Moderna Therapeutics and Millennium Pharmaceuticals, where he was responsible for developing novel platforms and leading discovery programs. Jesse earned his Ph.D. in Biological Chemistry from MIT and was a Harvard Origins Research Fellow.
KATE MOREAU, PhD
Associate Director
Kate Moreau is an Associate Director within the TechAtlas division of RA Capital Management. Kate’s primary responsibilities are to drive internal and external strategic and diligence initiatives and oversee the workflow and professional development of TechAtlas Associates. Prior to this role, Kate worked with the Venture team evaluating early stage investment opportunities and mapped a number of competitive landscapes, including ophthalmology, lower GI, and non-viral liver disease. Kate holds a BA in Molecular Biology and Biochemistry from Rutgers University, and a PhD in Biochemistry from MIT. Her doctoral research investigated the folding and aggregation of gamma-crystallins associated with cataract formation.
EMILY GREEN
Senior Graphic Designer
Emily Green is a Senior Graphic Designer at RA Capital Management. Emily’s primary responsibility at RA Capital is to create graphics, charts, and other visuals for competitive landscapes of drugs and medical devices for disease indications and capabilities. In addition, she is responsible for overseeing content management for the RA Capital website, and designing visual elements for other internal and external communications. Emily holds a BS in Graphic Design from James Madison University.
MATTHEW THERKELSEN, PhD
Associate
Matthew is an Associate within the TechAtlas division of RA Capital Management. Matthew’s primary responsibility at RA Capital is to create competitive landscapes of drugs and medical devices for disease indications and capabilities. Matt holds a PhD in Biological Sciences from Purdue University as well as BA in Biochemistry/Molecular Biology (and a Minor in Mathematics) from Hamilton College.